Genenta Science SpA ADR

Stock Chart, Company Information, and Scan Results

$1.85(as of Jun 24, 4:00 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Genenta Science SpA ADR Company Information, Fundamentals, and Technical Indicators

Stock Price$1.85
Ticker SymbolGNTA
ExchangeNasdaq
SectorHealthcare
IndustryBiotechnology
Employees9
CountyUSA
Market Cap$41.0M

Genenta Science S.p.A., a clinical-stage biotechnology company, develops hematopoietic stem cell gene therapies for the treatment of solid tumors in Italy. The company offers Temferon, which is in Phase 1/2a clinical trials for use in the treatment of glioblastoma multiforme in patients with unmethylated MGMT gene promoter. It is developing Temferon for use in the treatment of other solid tumor indications. In addition, the company develops biologic platform to deliver immunomodulatory molecules directly to the tumor by infiltrating monocytes/macrophages. Genenta Science S.p.A. was incorporated in 2014 and is headquartered in Milan, Italy.

Genenta Science SpA ADR In Our Stock Scanner

As of Jun 25, 2026
As of ---
As of ---
As of ---
example chart graphic
Scan Name: Cash SurplusScan Type: Stock Fundamentals
As of ---
As of ---

Join Our Free Email List

Get emails from us about ways to potentially make money in the stock market.